| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.39 | 0.02 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.35 | 0.02 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |